ArriVent BioPharma, Inc. (AVBP) vs Maze Therapeutics, Inc. (MAZE)
ArriVent BioPharma, Inc. and Maze Therapeutics, Inc. are both Biotechnology companies. ArriVent BioPharma, Inc. and Maze Therapeutics, Inc. are of similar size ($1.5B and $1.5B). Across the 10 metrics below, Maze Therapeutics, Inc. leads on 6 and ArriVent BioPharma, Inc. on 4.
Valuation
Profitability
| Metric | AVBP | MAZE | Biotechnology median |
|---|---|---|---|
| Gross margin | — | — | 65.16% |
| Operating margin | 0.00% | 0.00% | 0.00% |
| Net margin | 0.00% | 0.00% | 0.00% |
| Free cash flow margin | 0.00% | 0.00% | 0.00% |
| Return on equity | (53.10%) | (37.35%) | (57.72%) |
| Return on assets | (49.30%) | (31.99%) | (49.22%) |
| Return on invested capital | 0.00% | (112.36%) | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack